Fairfield, Bush & Co’s Lam Research LRCX Stock Holding History

Fairfield, Bush & Co’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-60	Closed	-$4.7K	–	310
2023 Q4	$4.7K	Buy	+60	New	+$4.09K	﹤0.01%	353

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fairfield, Bush & Co's LRCX Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Lam Research (LRCX) in Q1 2024, closing a stake of 60 shares — an estimated $4.7K sold.

Fairfield, Bush & Co first reported a position in LRCX in Q4 2023 and held it in 1 quarter. The position peaked at $4.7K in Q4 2023. 1,731 funds tracked by Wall St. Rank hold LRCX as of Q1 2024.

Fairfield, Bush & Co reported no remaining Lam Research position as of Q1 2024 after selling out during the quarter.
Fairfield, Bush & Co sold 60 Lam Research shares in Q1 2024, an estimated $4.7K.
Fairfield, Bush & Co first reported a position in Lam Research in Q4 2023 and held it in 1 quarter.
Fairfield, Bush & Co's Lam Research position peaked at $4.7K in Q4 2023.
1,731 funds tracked by Wall St. Rank held Lam Research as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.